Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription

BackgroundTranscription of HIV-1 genes is activated by HIV-1 Tat protein, which induces phosphorylation of RNA polymerase II (RNAPII) C-terminal domain (CTD) by CDK9/cyclin T1. Earlier we showed that CDK2/cyclin E phosphorylates HIV-1 Tat in vitro. We also showed that CDK2 induces HIV-1 transcription in vitro and that inhibition of CDK2 expression by RNA interference inhibits HIV-1 transcription and viral replication in cultured cells. In the present study, we analyzed whether Tat is phosphorylated in cultured cells by CDK2 and whether Tat phosphorylation has a regulatory effect on HIV-1 transcription.ResultsWe analyzed HIV-1 Tat phosphorylation by CDK2 in vitro and identified Ser16 and Ser46 residues of Tat as potential phosphorylation sites. Tat was phosphorylated in HeLa cells infected with Tat-expressing adenovirus and metabolically labeled with 32P. CDK2-specific siRNA reduced the amount and the activity of cellular CDK2 and significantly decreased phosphorylation of Tat. Tat co-migrated with CDK2 on glycerol gradient and co-immunoprecipitated with CDK2 from the cellular extracts. Tat was phosphorylated on serine residues in vivo, and mutations of Ser16 and Ser46 residues of Tat reduced Tat phosphorylation in vivo. Mutation of Ser16 and Ser46 residues of Tat reduced HIV-1 transcription in transiently transfected cells. The mutations of Tat also inhibited HIV-1 viral replication and Tat phosphorylation in the context of the integrated HIV-1 provirus. Analysis of physiological importance of the S16QP(K/R)19 and S46YGR49 sequences of Tat showed that Ser16 and Ser46 and R49 residues are highly conserved whereas mutation of the (K/R)19 residue correlated with non-progression of HIV-1 disease.ConclusionOur results indicate for the first time that Tat is phosphorylated in vivo; Tat phosphorylation is likely to be mediated by CDK2; and phosphorylation of Tat is important for HIV-1 transcription.

[1]  M. Barbacid,et al.  Driving the cell cycle to cancer. , 2003, Advances in experimental medicine and biology.

[2]  S. Nekhai,et al.  A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity , 1997, Journal of virology.

[3]  S. Nekhai,et al.  Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription , 2005, Retrovirology.

[4]  G. Hager,et al.  Induction of developmentally programmed cell death and activation of HIV by sodium butyrate. , 1994, Virology.

[5]  B. Berkhout,et al.  A Second-Site Mutation That Restores Replication of a Tat-Defective Human Immunodeficiency Virus , 1999, Journal of Virology.

[6]  P. Fowler,et al.  Substrate Specificity of CDK2-Cyclin A , 2003, Journal of Biological Chemistry.

[7]  A. Rice,et al.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor , 1995, Journal of virology.

[8]  F. Kashanchi,et al.  Direct interaction of human TFIID with the HIV-1 transactivator Tat , 1994, Nature.

[9]  Chen Liang,et al.  Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression , 2005, Journal of Virology.

[10]  S. Nekhai,et al.  HIV-1 Tat interacts with LIS1 protein , 2005, Retrovirology.

[11]  B. Cullen,et al.  Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Nekhai,et al.  Nuclear Targeting of Protein Phosphatase-1 by HIV-1 Tat Protein* , 2005, Journal of Biological Chemistry.

[13]  Sergei Nekhai,et al.  HIV-1 Tat Interaction with RNA Polymerase II C-terminal Domain (CTD) and a Dynamic Association with CDK2 Induce CTD Phosphorylation and Transcription from HIV-1 Promoter* , 2002, The Journal of Biological Chemistry.

[14]  B. Cullen,et al.  Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus , 1993, Journal of virology.

[15]  M. Bukrinsky,et al.  Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. , 2002, AIDS research and human retroviruses.

[16]  B. Berkhout,et al.  Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. , 1992, The Journal of biological chemistry.

[17]  K. Pfeiffer,et al.  Electrophoretic separation of multiprotein complexes from blood platelets and cell lines: Technique for the analysis of diseases with defects in oxidative phosphorylation , 1996, Electrophoresis.

[18]  M. Malim,et al.  Phosphorylation of the rev gene product of human immunodeficiency virus type 1 , 1988, Journal of virology.

[19]  K. Jeang,et al.  A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter , 2003, Nature Cell Biology.

[20]  H. Okamoto,et al.  The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. , 1997, Genes & development.

[21]  B. Berkhout,et al.  Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. , 1997, Virology.

[22]  E. Verdin,et al.  Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity , 1999, Current Biology.

[23]  Michael R Green,et al.  HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs , 2005, PLoS biology.

[24]  R. Kobayashi,et al.  The Tat Protein of Human Immunodeficiency Virus Type 1 Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR* , 1997, The Journal of Biological Chemistry.

[25]  Frank McCormick,et al.  Proliferation of cancer cells despite CDK2 inhibition. , 2003, Cancer cell.

[26]  M. L. Souto,et al.  Okadaic acid, useful tool for studying cellular processes. , 2002, Current medicinal chemistry.

[27]  R. Benarous,et al.  NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP. , 2003, Biochemistry.

[28]  H. Cheng,et al.  The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes. , 1999, Virology.

[29]  Sergei Nekhai,et al.  Nuclear Protein Phosphatase-1 Regulates HIV-1 Transcription* , 2003, Journal of Biological Chemistry.

[30]  A. Burny,et al.  HIV‐1 Tat transcriptional activity is regulated by acetylation , 1999, The EMBO journal.

[31]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[32]  D. Gabuzda,et al.  Mitogen-activated Protein Kinase Phosphorylates and Regulates the HIV-1 Vif Protein* , 1998, The Journal of Biological Chemistry.

[33]  F. Carlotti,et al.  Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein , 1990, Journal of virology.

[34]  T. Hunter,et al.  Detection and quantification of phosphotyrosine in proteins. , 1983, Methods in enzymology.

[35]  Sergei Nekhai,et al.  Inhibition of PP2A by LIS1 increases HIV-1 gene expression , 2006, Retrovirology.

[36]  R. Berro,et al.  RNA interference directed to CDK2 inhibits HIV-1 transcription. , 2005, Virology.

[37]  B. Berkhout,et al.  Effects of integration and replication on transcription of the HIV-1 long terminal repeat. , 1993, The Journal of biological chemistry.

[38]  K. Jeang,et al.  Differential acetylation of Tat coordinates its interaction with the co‐activators cyclin T1 and PCAF , 2002, The EMBO journal.

[39]  A. Rice,et al.  Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. , 1993, Virology.

[40]  F. Kashanchi,et al.  Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. , 2000, Virology.

[41]  B. Berkhout,et al.  On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. , 1998, AIDS research and human retroviruses.

[42]  F. Kashanchi,et al.  Tat gets the "green" light on transcription initiation , 2005, Retrovirology.

[43]  M. Giacca,et al.  HIV Tat, its TARgets and the control of viral gene expression. , 2003, FEMS microbiology letters.

[44]  S. Kim,et al.  Purification and crystallization of human cyclin-dependent kinase 2. , 1993, Journal of molecular biology.

[45]  A. Rice,et al.  TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Nekhai,et al.  Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator. , 2000, Virology.

[47]  S. Reed.  Control of the G1/S transition. , 1997, Cancer surveys.

[48]  S. Elledge,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.

[49]  F. Kashanchi,et al.  Antiviral Activity of CYC202 in HIV-1-infected Cells* , 2005, Journal of Biological Chemistry.

[50]  G. Stark,et al.  Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation* , 2001, The Journal of Biological Chemistry.

[51]  S. Nekhai,et al.  HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription. , 2002, The Biochemical journal.

[52]  H. True,et al.  Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation. , 1997, Biochemistry.

[53]  J. Karn,et al.  Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation , 2002, Molecular and Cellular Biology.

[54]  M. Emerman,et al.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.

[55]  K. Bennett,et al.  Phosphopeptide detection and sequencing by matrix-assisted laser desorption/ionization quadrupole time-of-flight tandem mass spectrometry. , 2002, Journal of mass spectrometry : JMS.